GENB (Generate Biomedicines) Common Stock: $0.03 Mil (As of Dec. 2025)


GENB Generate Biomedicines Inc GENB
6 GF Score
Price $16.92
! 2 Warning Signs
View Full Analysis

What is Generate Biomedicines Common Stock?

Generate Biomedicines GENB +2.18% 6 Common Stock is $0.03 Mil as of Dec. 2025. GuruFocus rates GENB with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Generate Biomedicines's quarterly common stock increased from . 20 ($0.00 Mil) to Dec. 2024 ($0.03 Mil) but then stayed the same from Dec. 2024 ($0.03 Mil) to Dec. 2025 ($0.03 Mil).

Generate Biomedicines's annual common stock increased from . 20 ($0.00 Mil) to Dec. 2024 ($0.03 Mil) but then stayed the same from Dec. 2024 ($0.03 Mil) to Dec. 2025 ($0.03 Mil).

Generate Biomedicines Common Stock Historical Data

* Premium members only.

The historical data trend for Generate Biomedicines's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Generate Biomedicines Common Stock Chart

Generate Biomedicines Annual Data
Trend Dec24 Dec25
Common Stock
0.03 0.03

Generate Biomedicines Semi-Annual Data
Dec24 Dec25
Common Stock 0.03 0.03
GENB
6GF Score
Generate Biomedicines Inc GENB
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Generate Biomedicines Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.03 Mil mean?
Generate Biomedicines (GENB) has a Common Stock of $0.03 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Generate Biomedicines and its competitors.
Is Generate Biomedicines' Common Stock too high?
Generate Biomedicines' current Common Stock is $0.03 Mil. Overall, Generate Biomedicines has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Generate Biomedicines' Common Stock compare to PVLA and SLBT?
Generate Biomedicines' Common Stock of $0.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Generate Biomedicines and its competitors. Generate Biomedicines's current Common Stock is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generate Biomedicines stock overvalued right now?
Generate Biomedicines (GENB) has a current Common Stock of $0.03 Mil. The current Common Stock is $0.03 Mil. Generate Biomedicines' overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Generate Biomedicines (GENB), the current Common Stock is $0.03 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Generate Biomedicines Business Description

Address 101 South Street, Suite 900, Somerville, MA, USA, 02143
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
6GF Score

Get the complete analysis for GENB

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.92
Price